In stock for ordering This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment. Publication ID SMA16-4978 Publication Date October 2016 Format Guidelines or Manual Download A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders PDF 1.54 MB Order Print Publication Quantity Max Order Limit 1 Orders exceeding the maximum quantity limit require authorization. Find Related Information Audience Professional Care Providers Program Planners, Administrators, & Project Managers Public Health Professionals Population Group Children of Parents with Substance Use or Abuse Problems People with Substance Use or Abuse Problems as Population Group Pregnant Women You May Also Be Interested In Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions. Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances. Rx Pain Medications, Know the Options, Get the Facts: The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on using Naloxone as a deterrent to overdose. Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. Behavioral Health Barometer, Volume 4 This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. The state-level Barometers contain valuable insight into the behavioral health needs and the unique challenges faced by communities across the country. This analysis can help public health authorities and others determine the best ways of meeting behavioral health care needs and disparities among various communities. Addressing Viral Hepatitis in People With Substance Use Disorders This quick guide helps clinicians address viral hepatitis when working with people living with substance use disorders. It covers hepatitis prevention, screening, treatment, and service coordination, and guides administrators on how to add or improve hepatitis services.
